BVI Medical announced today that it received CE mark for its Virtuoso next-generation phaco-vitrectomy surgical platform.

BVI’s next-generation cataract and vitreoretinal procedure platform has been developed with features that are intended at improving patient outcomes.

CE Mark under the European Union Medical Device Regulation (EU MDR) achieved for Virtuoso®, BVI’s first dual-function ...

Milestone strengthens the company’s leadership in advanced IOL innovation FINEVISION HP, with millions of implantations worldwide, will now be available to U.S. patients Proprietary design features ...

CE Mark under the European Union Medical Device Regulation (EU MDR) achieved for Virtuoso, BVI's first dual-function phaco-vitrectomy platform designed to deliver advanced control, efficiency, and ver ...